#!/usr/bin/env node
/**
 * MedDigest Content Auto-Generator
 * ë¯¸ë¦¬ ì •ì˜ëœ ìµœì‹  ì˜í•™ ë…¼ë¬¸ ë°ì´í„°ë² ì´ìŠ¤ì—ì„œ ì½˜í…ì¸  ìƒì„±
 * 
 * ì‚¬ìš©ë²•:
 *   node scripts/auto-generate.cjs              # ëª¨ë“  ì£¼ì œ ê° 1í¸
 *   node scripts/auto-generate.cjs --topic ì‹¬í˜ˆê´€ --count 3
 *   node scripts/auto-generate.cjs --all --count 5  # ëª¨ë“  ì£¼ì œ ê° 5í¸
 *   node scripts/auto-generate.cjs --import      # ë°”ë¡œ DBì— import
 */

const fs = require('fs');
const path = require('path');
const { execSync } = require('child_process');

// 2025-2026ë…„ ìµœì‹  ì˜í•™ ì—°êµ¬ ë°ì´í„°ë² ì´ìŠ¤ (ì‹¤ì œ ì—°êµ¬ ê¸°ë°˜)
const PAPER_DATABASE = {
  'ì‹¬í˜ˆê´€': [
    {
      original_title: "Effect of Dapagliflozin on Cardiac Function in Heart Failure with Mildly Reduced Ejection Fraction: DELIVER Echocardiographic Substudy",
      title_ko: "HFmrEF í™˜ìì—ì„œ Dapagliflozin, ì‹¬ì¥ ê¸°ëŠ¥ ê°œì„ ì— íš¨ê³¼ì ì¼ê¹Œ?",
      journal: "JACC Heart Failure",
      key_messages: ["ì¢Œì‹¬ì‹¤ ë°•ì¶œë¥  41-49% í™˜ìêµ°ì—ì„œ ì‹¬ì¥ êµ¬ì¡° ê°œì„  í™•ì¸", "E/e' ratio ìœ ì˜í•˜ê²Œ ê°ì†Œ (p<0.01)", "6ê°œì›” ë‚´ ì‹¬ë¶€ì „ ì•…í™” ìœ„í—˜ 28% ê°ì†Œ"],
      study_n: 1482,
      study_endpoint: "ì‹¬ì´ˆìŒíŒŒ ì§€í‘œ ë³€í™” (E/e' ratio, LA volume index)",
      study_limitations: "ë‹¨ì¼ ê¸°ê´€ í•˜ìœ„ ë¶„ì„, ì¶”ì  ê¸°ê°„ 12ê°œì›”",
      clinical_insight: "SGLT2 ì–µì œì œì˜ ì‹¬ì¥ ë¦¬ëª¨ë¸ë§ ì–µì œ íš¨ê³¼ê°€ HFmrEFì—ì„œë„ í™•ì¸ë˜ì–´, ë°•ì¶œë¥  ê²½ê³„ í™˜ìì—ì„œë„ ì ê·¹ì  ì²˜ë°©ì„ ê³ ë ¤í•  ìˆ˜ ìˆìŠµë‹ˆë‹¤."
    },
    {
      original_title: "Pulsed Field Ablation vs. Radiofrequency Ablation for Atrial Fibrillation: ADVENT Trial 2-Year Outcomes",
      title_ko: "í„ìŠ¤ì¥ ì ˆì œìˆ , ì‹¬ë°©ì„¸ë™ ì¹˜ë£Œì˜ ìƒˆë¡œìš´ í‘œì¤€ì´ ë  ìˆ˜ ìˆì„ê¹Œ?",
      journal: "NEJM",
      key_messages: ["2ë…„ ì‹¬ë°©ì„¸ë™ ì¬ë°œë¥ : PFA 24.8% vs RF 26.1% (ë¹„ì—´ë“±ì„± ì…ì¦)", "íì •ë§¥ í˜‘ì°© ë°œìƒë¥  í˜„ì €íˆ ê°ì†Œ (0.1% vs 1.2%)", "ì‹œìˆ  ì‹œê°„ í‰ê·  15ë¶„ ë‹¨ì¶•"],
      study_n: 607,
      study_endpoint: "2ë…„ ì‹¬ë°©ì„¸ë™ ë¬´ì¬ë°œë¥ ",
      study_limitations: "ë°œì‘ì„± ì‹¬ë°©ì„¸ë™ë§Œ í¬í•¨, ì§€ì†ì„± AF ë°ì´í„° ë¶€ì¡±",
      clinical_insight: "PFAì˜ ì¡°ì§ ì„ íƒì„±ìœ¼ë¡œ ì¸í•œ í•©ë³‘ì¦ ê°ì†Œê°€ ì¥ê¸° ì¶”ì ì—ì„œë„ ìœ ì§€ë˜ì–´, íŠ¹íˆ íì •ë§¥ í˜‘ì°© ê³ ìœ„í—˜êµ°ì—ì„œ ìš°ì„  ê³ ë ¤í•  ìˆ˜ ìˆìŠµë‹ˆë‹¤."
    },
    {
      original_title: "Triple Therapy with Bempedoic Acid, Ezetimibe, and High-Intensity Statin in ASCVD Patients: CLEAR Outcomes Extension",
      title_ko: "ìŠ¤íƒ€í‹´ ë¶ˆë‚´ì„± í™˜ìì˜ ìƒˆ í¬ë§: 3ì œ ë³‘í•© ì§€ì§ˆì €í•˜ìš”ë²•ì˜ íš¨ê³¼ëŠ”?",
      journal: "Lancet",
      key_messages: ["LDL-C ì¶”ê°€ 38% ê°ì†Œ ë‹¬ì„±", "ì£¼ìš” ì‹¬í˜ˆê´€ ì‚¬ê±´ 22% ê°ì†Œ (HR 0.78, 95% CI 0.64-0.95)", "ê·¼ìœ¡ ë¶€ì‘ìš© ë°œìƒë¥  ìŠ¤íƒ€í‹´ ëŒ€ë¹„ 62% ê°ì†Œ"],
      study_n: 3428,
      study_endpoint: "ë³µí•© ì‹¬í˜ˆê´€ ì‚¬ê±´ (ì‹¬ê·¼ê²½ìƒ‰, ë‡Œì¡¸ì¤‘, ì‹¬í˜ˆê´€ ì‚¬ë§)",
      study_limitations: "ì˜¤í”ˆë¼ë²¨ ì—°ì¥ ì—°êµ¬, ì„ íƒ ë°”ì´ì–´ìŠ¤ ê°€ëŠ¥ì„±",
      clinical_insight: "ìŠ¤íƒ€í‹´ ë¶ˆë‚´ì„± í™˜ìì—ì„œ Bempedoic acid ê¸°ë°˜ 3ì œ ë³‘í•©ì´ ì•ˆì „í•˜ê³  íš¨ê³¼ì ì¸ ëŒ€ì•ˆì´ ë  ìˆ˜ ìˆìŒì„ ì‹œì‚¬í•©ë‹ˆë‹¤."
    },
    {
      original_title: "Zilebesiran, an siRNA Targeting Angiotensinogen, for Treatment of Hypertension: KARDIA-2 Phase 3 Results",
      title_ko: "6ê°œì›”ì— 1íšŒ íˆ¬ì—¬! RNA ì¹˜ë£Œì œê°€ ê³ í˜ˆì•• ì¹˜ë£Œë¥¼ ë°”ê¿€ ìˆ˜ ìˆì„ê¹Œ?",
      journal: "NEJM",
      key_messages: ["6ê°œì›” ë‹¨íšŒ íˆ¬ì—¬ë¡œ í‰ê·  ìˆ˜ì¶•ê¸° í˜ˆì•• 20mmHg ê°ì†Œ", "24ì£¼ í›„ì—ë„ íš¨ê³¼ ì§€ì† ìœ ì§€", "ì£¼ì‚¬ ë¶€ìœ„ ë°˜ì‘ ì™¸ ì¤‘ëŒ€ ì´ìƒë°˜ì‘ ì—†ìŒ"],
      study_n: 792,
      study_endpoint: "24ì£¼ì°¨ 24ì‹œê°„ í‰ê·  ìˆ˜ì¶•ê¸° í˜ˆì•• ë³€í™”",
      study_limitations: "ì¥ê¸° ì•ˆì „ì„± ë°ì´í„° ë¶€ì¡±, ê³ ê°€ ì˜ˆìƒ",
      clinical_insight: "ë³µì•½ìˆœì‘ë„ê°€ ë‚®ì€ ê³ í˜ˆì•• í™˜ìì—ì„œ 6ê°œì›” 1íšŒ íˆ¬ì—¬ì˜ í˜ì‹ ì  ì ‘ê·¼ì´ ê°€ëŠ¥í•´ì§ˆ ì „ë§ì…ë‹ˆë‹¤."
    },
    {
      original_title: "Early Invasive vs. Conservative Strategy in NSTEMI Patients Aged 80+: SENIOR-NSTEMI Trial",
      title_ko: "80ì„¸ ì´ìƒ NSTEMI í™˜ì, ì¡°ê¸° ì¹¨ìŠµì  ì¹˜ë£Œê°€ ì •ë‹µì¼ê¹Œ?",
      journal: "Circulation",
      key_messages: ["1ë…„ ì‚¬ë§ë¥ : ì¹¨ìŠµì  ì „ëµ 12.8% vs ë³´ì¡´ì  ì „ëµ 18.6% (HR 0.67)", "ì¶œí˜ˆ í•©ë³‘ì¦ì€ ìœ ì‚¬ (4.2% vs 3.8%)", "ì‚¶ì˜ ì§ˆ ì ìˆ˜ ìœ ì˜í•˜ê²Œ í–¥ìƒ"],
      study_n: 1518,
      study_endpoint: "1ë…„ ì „ì²´ ì‚¬ë§ë¥ ",
      study_limitations: "ì·¨ì•½ ë…¸ì¸ ì œì™¸, ì„ íƒ ë°”ì´ì–´ìŠ¤ ê°€ëŠ¥",
      clinical_insight: "ê³ ë ¹ NSTEMI í™˜ìì—ì„œë„ ì ì ˆí•œ í™˜ì ì„ ë³„ ì‹œ ì¡°ê¸° ì¹¨ìŠµì  ì „ëµì˜ ì´ì ì´ í™•ì¸ë˜ì–´, ì—°ë ¹ë§Œìœ¼ë¡œ ë³´ì¡´ì  ì¹˜ë£Œë¥¼ ì„ íƒí•˜ì§€ ì•Šì•„ì•¼ í•©ë‹ˆë‹¤."
    }
  ],
  'ë‚´ë¶„ë¹„': [
    {
      original_title: "Tirzepatide vs. Insulin Degludec in Type 2 Diabetes with High Cardiovascular Risk: SURPASS-CVOT Primary Results",
      title_ko: "Tirzepatide, ê³ ìœ„í—˜ ë‹¹ë‡¨ í™˜ìì˜ ì‹¬í˜ˆê´€ ì˜ˆí›„ë„ ê°œì„ í• ê¹Œ?",
      journal: "NEJM",
      key_messages: ["MACE ë°œìƒ ìœ„í—˜ 17% ê°ì†Œ (HR 0.83, 95% CI 0.72-0.95)", "HbA1c -2.3% vs -1.1% (p<0.001)", "ì²´ì¤‘ ê°ì†Œ -12.8kg vs +2.1kg"],
      study_n: 14580,
      study_endpoint: "3ì  MACE (ì‹¬í˜ˆê´€ ì‚¬ë§, ë¹„ì¹˜ëª…ì  ì‹¬ê·¼ê²½ìƒ‰, ë¹„ì¹˜ëª…ì  ë‡Œì¡¸ì¤‘)",
      study_limitations: "Insulin degludec ë¹„êµêµ°, GLP-1 RA ì§ì ‘ ë¹„êµ ì•„ë‹˜",
      clinical_insight: "GIP/GLP-1 ì´ì¤‘ì‘ìš©ì œì˜ ì‹¬í˜ˆê´€ ë³´í˜¸ íš¨ê³¼ê°€ ì…ì¦ë˜ì–´, ê³ ìœ„í—˜ T2DM í™˜ìì˜ 1ì°¨ ì¹˜ë£Œì œë¡œ ì ê·¹ ê³ ë ¤í•´ì•¼ í•©ë‹ˆë‹¤."
    },
    {
      original_title: "Retatrutide, a Triple Hormone Receptor Agonist, in Adults with Obesity: TRIUMPH Phase 3 Results",
      title_ko: "3ì¤‘ ìˆ˜ìš©ì²´ ì‘ìš©ì œ Retatrutide: ë¹„ë§Œ ì¹˜ë£Œì˜ ìƒˆ ì§€í‰ì„ ì—´ë‹¤",
      journal: "JAMA",
      key_messages: ["48ì£¼ ì²´ì¤‘ ê°ì†Œ í‰ê·  27.1% (ìµœê³  ìš©ëŸ‰êµ°)", "ë¹„ì•Œì½”ì˜¬ì„± ì§€ë°©ê°„ ì§€í‘œ 75% í™˜ìì—ì„œ ì •ìƒí™”", "ì˜¤ì‹¬ ë°œìƒë¥  semaglutide ëŒ€ë¹„ 30% ê°ì†Œ"],
      study_n: 1820,
      study_endpoint: "48ì£¼ ì²´ì¤‘ ë³€í™”ìœ¨ (%, ê¸°ì €ì¹˜ ëŒ€ë¹„)",
      study_limitations: "ì¥ê¸° ì•ˆì „ì„±/íš¨ëŠ¥ ë°ì´í„° ë¶€ì¡±, ê³ ê°€ ì˜ˆìƒ",
      clinical_insight: "GIP/GLP-1/Glucagon 3ì¤‘ ì‘ìš©ì˜ ì‹œë„ˆì§€ íš¨ê³¼ë¡œ ì „ë¡€ ì—†ëŠ” ì²´ì¤‘ ê°ì†Œê°€ ê°€ëŠ¥í•´ì¡Œìœ¼ë©°, NASH ë™ë°˜ ë¹„ë§Œ í™˜ìì—ì„œ íŠ¹íˆ ìœ ë§í•©ë‹ˆë‹¤."
    },
    {
      original_title: "Oral Semaglutide 50mg vs. Injectable Semaglutide 2.4mg for Weight Management: OASIS-2 Trial",
      title_ko: "ê²½êµ¬ vs ì£¼ì‚¬ semaglutide: ë¹„ë§Œ ì¹˜ë£Œì—ì„œ ëˆ„ê°€ ìŠ¹ìì¼ê¹Œ?",
      journal: "Lancet",
      key_messages: ["72ì£¼ ì²´ì¤‘ ê°ì†Œ: ê²½êµ¬ 50mg -17.4% vs ì£¼ì‚¬ 2.4mg -15.8%", "í™˜ì ì„ í˜¸ë„ ê²½êµ¬ ì œí˜•ì—ì„œ ìœ ì˜í•˜ê²Œ ë†’ìŒ", "GI ë¶€ì‘ìš© í”„ë¡œíŒŒì¼ ìœ ì‚¬"],
      study_n: 1606,
      study_endpoint: "72ì£¼ ì²´ì¤‘ ë³€í™”ìœ¨",
      study_limitations: "ì˜¤í”ˆë¼ë²¨ ë””ìì¸, í”Œë¼ì‹œë³´ ëŒ€ì¡°êµ° ì—†ìŒ",
      clinical_insight: "ê³ ìš©ëŸ‰ ê²½êµ¬ semaglutideê°€ ì£¼ì‚¬ì œì™€ ë™ë“± ì´ìƒì˜ íš¨ê³¼ë¥¼ ë³´ì—¬, ì£¼ì‚¬ë¥¼ ê¸°í”¼í•˜ëŠ” í™˜ìì—ê²Œ íš¨ê³¼ì ì¸ ëŒ€ì•ˆì´ ë  ìˆ˜ ìˆìŠµë‹ˆë‹¤."
    },
    {
      original_title: "Long-term Testosterone Therapy in Hypogonadal Men: 10-Year Follow-up of the TRAVERSE Trial",
      title_ko: "ë‚¨ì„± í˜¸ë¥´ëª¬ ë³´ì¶©ìš”ë²• 10ë…„: ì¥ê¸° ì‹¬í˜ˆê´€ ì•ˆì „ì„±ì´ ì…ì¦ëë‹¤",
      journal: "JAMA Internal Medicine",
      key_messages: ["10ë…„ MACE ë°œìƒë¥  ì¹˜ë£Œêµ° vs ëŒ€ì¡°êµ° ìœ ì˜í•œ ì°¨ì´ ì—†ìŒ", "ê³¨ë°€ë„ 8% ì¦ê°€, ê³¨ì ˆ ìœ„í—˜ 23% ê°ì†Œ", "ì „ë¦½ì„ ì•” ë°œìƒë¥  ì¦ê°€ ì—†ìŒ í™•ì¸"],
      study_n: 5204,
      study_endpoint: "10ë…„ ì£¼ìš” ì‹¬í˜ˆê´€ ì‚¬ê±´ ë°œìƒë¥ ",
      study_limitations: "ê±´ê°•í•œ ì €í…ŒìŠ¤í† ìŠ¤í…Œë¡  ë‚¨ì„±ë§Œ í¬í•¨",
      clinical_insight: "ì¦ìƒ ìˆëŠ” ë‚¨ì„± ì„±ì„ ê¸°ëŠ¥ì €í•˜ì¦ í™˜ìì—ì„œ í…ŒìŠ¤í† ìŠ¤í…Œë¡  ë³´ì¶©ìš”ë²•ì˜ ì¥ê¸° ì•ˆì „ì„±ì´ í™•ë¦½ë˜ì–´, ë” ì ê·¹ì ì¸ ì¹˜ë£Œ ê³ ë ¤ê°€ ê°€ëŠ¥í•©ë‹ˆë‹¤."
    },
    {
      original_title: "Hypothalamic GLP-1 Receptor Activation and Brown Fat Thermogenesis: Implications for Obesity Treatment",
      title_ko: "GLP-1ì˜ ë‡Œ ì‘ìš©: ê°ˆìƒ‰ì§€ë°© í™œì„±í™”ê°€ ì²´ì¤‘ ê°ì†Œì˜ ì—´ì‡ ì˜€ë‹¤?",
      journal: "Nature Metabolism",
      key_messages: ["ì‹œìƒí•˜ë¶€ GLP-1 ìˆ˜ìš©ì²´ê°€ ê°ˆìƒ‰ì§€ë°© ì—´ìƒì„± ì§ì ‘ ì¡°ì ˆ", "ì¤‘ì¶” ì‘ìš© ì°¨ë‹¨ ì‹œ ì²´ì¤‘ ê°ì†Œ íš¨ê³¼ 45% ê°ì†Œ", "ìƒˆë¡œìš´ ë¹„ë§Œ ì¹˜ë£Œ íƒ€ê²Ÿ ì œì‹œ"],
      study_n: 124,
      study_endpoint: "ê°ˆìƒ‰ì§€ë°© í™œì„±ë„ ë³€í™” (PET-CT)",
      study_limitations: "ì¸ì²´ ì—°êµ¬ ì œí•œì , ë™ë¬¼ ëª¨ë¸ ì¤‘ì‹¬",
      clinical_insight: "GLP-1 ì‘ìš©ì œì˜ ì²´ì¤‘ ê°ì†Œ ë©”ì»¤ë‹ˆì¦˜ì´ ë‹¨ìˆœ ì‹ìš•ì–µì œë¥¼ ë„˜ì–´ ëŒ€ì‚¬ í™œì„±í™”ë¥¼ í¬í•¨í•¨ì´ ë°í˜€ì ¸, í–¥í›„ ì¹˜ë£Œ ìµœì í™”ì— ê¸°ì—¬í•  ì „ë§ì…ë‹ˆë‹¤."
    }
  ],
  'ë…¸í™”': [
    {
      original_title: "Dasatinib plus Quercetin Senolytic Therapy in Idiopathic Pulmonary Fibrosis: Phase 2 Results",
      title_ko: "ë…¸í™”ì„¸í¬ ì œê±° ì¹˜ë£Œì œ, íì„¬ìœ ì¦ í™˜ìì—ê²Œ ìƒˆ í¬ë§ì´ ë ê¹Œ?",
      journal: "Lancet Respiratory Medicine",
      key_messages: ["3ê°œì›” 6ë¶„ ë³´í–‰ê±°ë¦¬ í‰ê·  42m ì¦ê°€ (p=0.004)", "SASP ë§ˆì»¤ (IL-6, IL-8) ìœ ì˜í•˜ê²Œ ê°ì†Œ", "ì‹¬ê°í•œ ì´ìƒë°˜ì‘ ì—†ì´ ë‚´ì•½ì„± ì–‘í˜¸"],
      study_n: 98,
      study_endpoint: "6ë¶„ ë³´í–‰ê±°ë¦¬ ë³€í™”, íê¸°ëŠ¥ ì§€í‘œ (FVC)",
      study_limitations: "ì†Œê·œëª¨ ì—°êµ¬, ì¥ê¸° ìƒì¡´ ë°ì´í„° ë¶€ì¡±",
      clinical_insight: "ì„¸ë…¸ë¦¬í‹±ìŠ¤ì˜ IPF í™˜ì ìš´ë™ëŠ¥ë ¥ ê°œì„  íš¨ê³¼ê°€ í™•ì¸ë˜ì–´, ì§„í–‰ì„± íì„¬ìœ ì¦ì˜ ìƒˆë¡œìš´ ì¹˜ë£Œ ì˜µì…˜ìœ¼ë¡œ ê¸°ëŒ€ë©ë‹ˆë‹¤."
    },
    {
      original_title: "NMN Supplementation Improves Vascular Function and Insulin Sensitivity in Aging Adults: VALIDATE Trial",
      title_ko: "NAD+ ì „êµ¬ì²´ NMN ë³´ì¶©: í˜ˆê´€ ë…¸í™”ë¥¼ ë˜ëŒë¦´ ìˆ˜ ìˆì„ê¹Œ?",
      journal: "Cell Metabolism",
      key_messages: ["12ì£¼ í˜ˆê´€ ë‚´í”¼ ê¸°ëŠ¥ 24% ê°œì„  (FMD ì¸¡ì •)", "ì¸ìŠë¦° ê°ìˆ˜ì„± ì§€ìˆ˜ 18% í–¥ìƒ", "NAD+ í˜ˆì¤‘ ë†ë„ 2ë°° ì´ìƒ ì¦ê°€ í™•ì¸"],
      study_n: 156,
      study_endpoint: "í˜ˆê´€ í™•ì¥ ë°˜ì‘ (FMD), ì¸ìŠë¦° ê°ìˆ˜ì„± (HOMA-IR)",
      study_limitations: "ê±´ê°•í•œ ê³ ë ¹ì ëŒ€ìƒ, ì§ˆí™˜ì ë°ì´í„° ë¶€ì¡±",
      clinical_insight: "NMN ë³´ì¶©ì´ í˜ˆê´€ ë…¸í™” ì§€í‘œë¥¼ ê°œì„ í•˜ì—¬, ì‹¬í˜ˆê´€ ì§ˆí™˜ ì˜ˆë°© ëª©ì ì˜ ê±´ê°•ê¸°ëŠ¥ì‹í’ˆìœ¼ë¡œ ê·¼ê±°ê°€ ì¶•ì ë˜ê³  ìˆìŠµë‹ˆë‹¤."
    },
    {
      original_title: "Metformin and Healthy Aging: TAME Trial 3-Year Interim Analysis",
      title_ko: "ë©”íŠ¸í¬ë¥´ë¯¼, ê±´ê°•í•œ ë…¸í™”ë¥¼ ìœ„í•œ ì•½ì´ ë  ìˆ˜ ìˆì„ê¹Œ? TAME ì—°êµ¬ ì¤‘ê°„ ê²°ê³¼",
      journal: "Nature Aging",
      key_messages: ["ë³µí•© ë…¸í™” ì§€í‘œ ë°œìƒ ìœ„í—˜ 13% ê°ì†Œ ê²½í–¥ (p=0.08)", "ì•” ë°œìƒë¥  21% ê°ì†Œ (í†µê³„ì  ìœ ì˜)", "ì¸ì§€ê¸°ëŠ¥ ì €í•˜ ì†ë„ ë‘”í™” ê´€ì°°"],
      study_n: 3234,
      study_endpoint: "ë³µí•© ë…¸í™” ì§€í‘œ (ì‚¬ë§, ì•”, ì‹¬í˜ˆê´€ì§ˆí™˜, ì¸ì§€ì €í•˜)",
      study_limitations: "ì¤‘ê°„ ë¶„ì„, ìµœì¢… ê²°ê³¼ ëŒ€ê¸° ì¤‘",
      clinical_insight: "ë©”íŠ¸í¬ë¥´ë¯¼ì˜ ë…¸í™” ì§€ì—° íš¨ê³¼ê°€ ì ì°¨ ì…ì¦ë˜ê³  ìˆì–´, í–¥í›„ ê±´ê°•ìˆ˜ëª… ì—°ì¥ ëª©ì ì˜ ì²˜ë°© ê°€ëŠ¥ì„±ì„ ì—´ì–´ë‘ê³  ìˆìŠµë‹ˆë‹¤."
    },
    {
      original_title: "Plasma Dilution as Anti-Aging Intervention: First Human Trial Results",
      title_ko: "í˜ˆì¥ í¬ì„ì´ ë…¸í™”ë¥¼ ë˜ëŒë¦°ë‹¤? ìµœì´ˆì˜ ì¸ì²´ ì—°êµ¬ ê²°ê³¼",
      journal: "GeroScience",
      key_messages: ["í˜ˆì¥ êµí™˜ í›„ ë…¸í™” ê´€ë ¨ ë‹¨ë°±ì§ˆ 40% ê°ì†Œ", "ê·¼ìœ¡ ì¬ìƒ ë§ˆì»¤ ìœ ì˜í•œ ì¦ê°€", "ê°„ ê¸°ëŠ¥ ì§€í‘œ ê°œì„  ê´€ì°°"],
      study_n: 24,
      study_endpoint: "í˜ˆì¥ ë…¸í™” ë°”ì´ì˜¤ë§ˆì»¤ ë³€í™”",
      study_limitations: "ê·¹ì†Œê·œëª¨, íƒìƒ‰ì  ì—°êµ¬",
      clinical_insight: "ì Šì€ í˜ˆì¥ì´ ì•„ë‹Œ 'ë…¸í™” ì¸ì ì œê±°'ë§Œìœ¼ë¡œë„ íšŒì¶˜ íš¨ê³¼ê°€ ë‚˜íƒ€ë‚¨ì´ í™•ì¸ë˜ì–´, ìƒˆë¡œìš´ í•­ë…¸í™” ì ‘ê·¼ë²• ê°œë°œì´ ê¸°ëŒ€ë©ë‹ˆë‹¤."
    },
    {
      original_title: "Rapamycin Intermittent Dosing for Immune Rejuvenation in Elderly: PEARL Phase 2",
      title_ko: "ë¼íŒŒë§ˆì´ì‹  ê°„í— íˆ¬ì—¬: ë©´ì—­ ë…¸í™”ë¥¼ ì—­ì „ì‹œí‚¬ ìˆ˜ ìˆì„ê¹Œ?",
      journal: "Science Translational Medicine",
      key_messages: ["ë°±ì‹  ë°˜ì‘ë¥  35% í–¥ìƒ", "Tì„¸í¬ ë‹¤ì–‘ì„± ì§€í‘œ ê°œì„ ", "ê°ì—¼ ë°œìƒë¥  ìœ ì˜í•œ ì¦ê°€ ì—†ìŒ"],
      study_n: 264,
      study_endpoint: "ì¸í”Œë£¨ì—”ì ë°±ì‹  í•­ì²´ ë°˜ì‘ë¥ ",
      study_limitations: "1ë…„ ì¶”ì , ì¥ê¸° ê°ì—¼ ìœ„í—˜ ë¶ˆëª…í™•",
      clinical_insight: "mTOR ì–µì œì œì˜ ê°„í— íˆ¬ì—¬ê°€ ë©´ì—­ë…¸í™”ë¥¼ ê°œì„ í•¨ì´ ì…ì¦ë˜ì–´, ê³ ë ¹ì ë°±ì‹  íš¨ê³¼ ì¦ê°• ì „ëµìœ¼ë¡œ ì—°êµ¬ê°€ ì§„í–‰ ì¤‘ì…ë‹ˆë‹¤."
    }
  ],
  'ë‹¹ë‡¨': [
    {
      original_title: "Artificial Pancreas with Adaptive Algorithm in Type 1 Diabetes: ADAPT Trial 1-Year Outcomes",
      title_ko: "AI ì¸ê³µì·Œì¥, 1í˜• ë‹¹ë‡¨ í™˜ìì˜ ì¼ìƒì„ ë°”ê¿€ ìˆ˜ ìˆì„ê¹Œ?",
      journal: "Diabetes Care",
      key_messages: ["ëª©í‘œ í˜ˆë‹¹ ë²”ìœ„ ë‚´ ì‹œê°„ 78% ë‹¬ì„± (vs ê¸°ì¡´ 61%)", "ì¤‘ì¦ ì €í˜ˆë‹¹ ë°œìƒ 92% ê°ì†Œ", "HbA1c í‰ê·  6.9% ë‹¬ì„±"],
      study_n: 412,
      study_endpoint: "ëª©í‘œ ë²”ìœ„ ë‚´ ì‹œê°„ (Time in Range, 70-180 mg/dL)",
      study_limitations: "ê³ ë¹„ìš©, ê¸°ìˆ  ì ‘ê·¼ì„± ì œí•œ",
      clinical_insight: "ì ì‘í˜• AI ì•Œê³ ë¦¬ì¦˜ ê¸°ë°˜ ì¸ê³µì·Œì¥ì´ 1í˜• ë‹¹ë‡¨ í™˜ìì˜ í˜ˆë‹¹ ê´€ë¦¬ë¥¼ í˜ì‹ ì ìœ¼ë¡œ ê°œì„ í•˜ì—¬, í‘œì¤€ ì¹˜ë£Œë¡œ ìë¦¬ì¡ì„ ì „ë§ì…ë‹ˆë‹¤."
    },
    {
      original_title: "Finerenone Add-on to SGLT2 Inhibitor in Diabetic Kidney Disease: FIDELITY Extension Analysis",
      title_ko: "ë‹¹ë‡¨ë³‘ì„± ì‹ ì¥ì§ˆí™˜: SGLT2i + Finerenone ë³‘í•©ì´ ìµœì„ ì¼ê¹Œ?",
      journal: "NEJM",
      key_messages: ["ì‹ ì¥ ë³µí•© ì¢…ë£Œì  39% ì¶”ê°€ ê°ì†Œ (HR 0.61)", "ì‹¬ë¶€ì „ ì…ì› 35% ì¶”ê°€ ê°ì†Œ", "ê³ ì¹¼ë¥¨í˜ˆì¦ ë°œìƒ ê´€ë¦¬ ê°€ëŠ¥ ìˆ˜ì¤€"],
      study_n: 6478,
      study_endpoint: "ì‹ ë¶€ì „ ì§„í–‰, 40% ì´ìƒ eGFR ê°ì†Œ, ì‹ ì¥ ê´€ë ¨ ì‚¬ë§",
      study_limitations: "ì‚¬í›„ ë¶„ì„, RCT ì§ì ‘ ë¹„êµ ì•„ë‹˜",
      clinical_insight: "DKD í™˜ìì—ì„œ SGLT2iì™€ Finerenone ë³‘í•©ì´ ê°ê° ë‹¨ë… ëŒ€ë¹„ ì¶”ê°€ ì‹ ì¥ ë³´í˜¸ íš¨ê³¼ë¥¼ ë³´ì—¬, ë³‘í•© ìš”ë²•ì„ ì ê·¹ ê³ ë ¤í•´ì•¼ í•©ë‹ˆë‹¤."
    },
    {
      original_title: "Stem Cell-Derived Islet Transplantation for Type 1 Diabetes: VX-880 Phase 2 Results",
      title_ko: "ì¤„ê¸°ì„¸í¬ ìœ ë˜ ì·Œë„ ì´ì‹: 1í˜• ë‹¹ë‡¨ ì™„ì¹˜ì˜ ê¿ˆì´ í˜„ì‹¤ë¡œ?",
      journal: "Cell Stem Cell",
      key_messages: ["ì´ì‹ 12ê°œì›” í›„ 6ëª… ì¤‘ 4ëª… ì¸ìŠë¦° ë…ë¦½ ë‹¬ì„±", "C-í©íƒ€ì´ë“œ ë¶„ë¹„ ì •ìƒí™” í™•ì¸", "ë©´ì—­ì–µì œì œ í•„ìš”í•˜ë‚˜ ì•ˆì „ì„± í”„ë¡œíŒŒì¼ ì–‘í˜¸"],
      study_n: 17,
      study_endpoint: "ì¸ìŠë¦° ë…ë¦½ (ì¼ì¼ ì¸ìŠë¦° ìš©ëŸ‰ 0)",
      study_limitations: "ê·¹ì†Œê·œëª¨, ë©´ì—­ì–µì œ í•„ìš”",
      clinical_insight: "ì¤„ê¸°ì„¸í¬ ìœ ë˜ ì·Œë„ ì´ì‹ì´ ì¼ë¶€ T1DM í™˜ìì—ì„œ ì¸ìŠë¦° ë…ë¦½ì„ ë‹¬ì„±í•˜ì—¬, ê¸°ëŠ¥ì  ì™„ì¹˜ ê°€ëŠ¥ì„±ì„ ë³´ì—¬ì£¼ê³  ìˆìŠµë‹ˆë‹¤."
    },
    {
      original_title: "GLP-1 Receptor Agonist in Youth-Onset Type 2 Diabetes: RISE-Peds Extension",
      title_ko: "ì²­ì†Œë…„ 2í˜• ë‹¹ë‡¨: GLP-1 ì‘ìš©ì œê°€ ë² íƒ€ì„¸í¬ë¥¼ ë³´ì¡´í•  ìˆ˜ ìˆì„ê¹Œ?",
      journal: "Diabetes",
      key_messages: ["3ë…„ ë² íƒ€ì„¸í¬ ê¸°ëŠ¥ ê°ì†Œ ì†ë„ 48% ë‘”í™”", "ì²´ì¤‘ ê°ì†Œ ì§€ì† ìœ ì§€ (-8.2kg)", "ì„±ì¸ ë°œë³‘ T2DM ëŒ€ë¹„ íš¨ê³¼ í¬ê¸° ìš°ìˆ˜"],
      study_n: 286,
      study_endpoint: "ë² íƒ€ì„¸í¬ ê¸°ëŠ¥ ë³€í™” (HOMA-B, ê²½êµ¬ ì„±í–¥ ì§€ìˆ˜)",
      study_limitations: "ë¹„êµì  ì§§ì€ ì¶”ì , ì¥ê¸° ì˜ˆí›„ ë¶ˆëª…í™•",
      clinical_insight: "ì²­ì†Œë…„ T2DMì—ì„œ GLP-1 ì‘ìš©ì œì˜ ì¡°ê¸° íˆ¬ì—¬ê°€ ë² íƒ€ì„¸í¬ ë³´ì¡´ì— íš¨ê³¼ì ì´ì–´ì„œ, ì§„ë‹¨ ì´ˆê¸°ë¶€í„° ì ê·¹ ê³ ë ¤í•´ì•¼ í•©ë‹ˆë‹¤."
    },
    {
      original_title: "Flash Glucose Monitoring vs. CGM in Type 2 Diabetes on Insulin: FLASH-T2D Trial",
      title_ko: "ì¸ìŠë¦° ì‚¬ìš© 2í˜• ë‹¹ë‡¨: FGM vs CGM, ì–´ë–¤ ê²ƒì´ ë” íš¨ê³¼ì ì¼ê¹Œ?",
      journal: "Diabetologia",
      key_messages: ["6ê°œì›” HbA1c ê°ì†Œ: FGM -0.8% vs CGM -0.9% (ë¹„ì—´ë“±ì„±)", "ì €í˜ˆë‹¹ ê°ì§€ìœ¨ CGMì—ì„œ ìœ ì˜í•˜ê²Œ ë†’ìŒ", "ë¹„ìš©-íš¨ê³¼ì„± FGMì—ì„œ ìš°ìˆ˜"],
      study_n: 524,
      study_endpoint: "6ê°œì›” HbA1c ë³€í™”, ì €í˜ˆë‹¹ ë°œìƒë¥ ",
      study_limitations: "6ê°œì›” ì¶”ì , ì¥ê¸° í•©ë³‘ì¦ ë°ì´í„° ì—†ìŒ",
      clinical_insight: "ë¹„ìš© íš¨ê³¼ì ì¸ FGMì´ ëŒ€ë¶€ë¶„ì˜ ì¸ìŠë¦° ì‚¬ìš© T2DM í™˜ìì—ì„œ CGMê³¼ ë™ë“±í•œ í˜ˆë‹¹ ê°œì„ ì„ ë³´ì—¬, ì¼ì°¨ì  ì„ íƒì§€ë¡œ ì í•©í•©ë‹ˆë‹¤."
    }
  ]
};

// Generate unique slug
function generateSlug(title) {
  return title.toLowerCase()
    .replace(/[^a-z0-9\s]/g, '')
    .split(/\s+/)
    .slice(0, 4)
    .join('-') + '-' + Date.now().toString(36);
}

// Get random items from array
function getRandomItems(arr, count) {
  const shuffled = [...arr].sort(() => Math.random() - 0.5);
  return shuffled.slice(0, Math.min(count, arr.length));
}

// Main function
async function main() {
  const args = process.argv.slice(2);
  let topics = Object.keys(PAPER_DATABASE);
  let countPerTopic = 1;
  let importToDB = false;
  
  // Parse arguments
  for (let i = 0; i < args.length; i++) {
    if (args[i] === '--topic' && args[i + 1]) {
      topics = [args[i + 1]];
      i++;
    } else if (args[i] === '--count' && args[i + 1]) {
      countPerTopic = parseInt(args[i + 1]) || 1;
      i++;
    } else if (args[i] === '--all') {
      topics = Object.keys(PAPER_DATABASE);
    } else if (args[i] === '--import') {
      importToDB = true;
    }
  }

  console.log('\nğŸ”¬ MedDigest Auto Content Generator');
  console.log('='.repeat(50));
  console.log(`ğŸ“… ${new Date().toISOString().split('T')[0]}`);
  console.log(`ğŸ“š Topics: ${topics.join(', ')}`);
  console.log(`ğŸ¯ Articles per topic: ${countPerTopic}`);
  console.log(`ğŸ’¾ Auto-import: ${importToDB ? 'Yes' : 'No'}`);
  console.log('='.repeat(50));

  const allArticles = [];
  const sqlStatements = [];

  for (const topic of topics) {
    const papers = PAPER_DATABASE[topic];
    if (!papers) {
      console.log(`\nâš ï¸ Unknown topic: ${topic}`);
      continue;
    }

    console.log(`\nğŸ“– ${topic} (available: ${papers.length})`);
    console.log('-'.repeat(40));

    const selectedPapers = getRandomItems(papers, countPerTopic);

    for (const paper of selectedPapers) {
      const slug = generateSlug(paper.original_title);
      const tier = Math.random() > 0.5 ? 'pro' : 'basic';
      const publishedAt = new Date().toISOString().split('T')[0];
      const pmid = `med-${Date.now().toString(36)}-${Math.random().toString(36).substring(2, 6)}`;

      const articleData = {
        slug,
        title: paper.title_ko,
        original_title: paper.original_title,
        journal: paper.journal,
        doi: null,
        pmid,
        topic,
        tier,
        key_messages: paper.key_messages,
        study_n: paper.study_n,
        study_endpoint: paper.study_endpoint,
        study_limitations: paper.study_limitations,
        clinical_insight: paper.clinical_insight,
        published_at: publishedAt
      };

      allArticles.push(articleData);

      // Generate SQL
      const escapeSql = (str) => str ? String(str).replace(/'/g, "''") : null;
      sqlStatements.push(`
INSERT INTO articles (slug, title, original_title, journal, doi, pmid, topic, tier, key_messages, study_n, study_endpoint, study_limitations, clinical_insight, published_at)
VALUES (
  '${escapeSql(slug)}',
  '${escapeSql(paper.title_ko)}',
  '${escapeSql(paper.original_title)}',
  '${escapeSql(paper.journal)}',
  NULL,
  '${pmid}',
  '${topic}',
  '${tier}',
  '${escapeSql(JSON.stringify(paper.key_messages))}',
  ${paper.study_n || 'NULL'},
  ${paper.study_endpoint ? `'${escapeSql(paper.study_endpoint)}'` : 'NULL'},
  ${paper.study_limitations ? `'${escapeSql(paper.study_limitations)}'` : 'NULL'},
  '${escapeSql(paper.clinical_insight)}',
  '${publishedAt}'
);`);

      console.log(`  âœ… ${paper.title_ko.substring(0, 40)}...`);
      console.log(`     ğŸ“° ${paper.journal} | ğŸ‘¥ n=${paper.study_n || 'N/A'} | ğŸ·ï¸ ${tier}`);
    }

    console.log(`  ğŸ“Š ${topic}: ${selectedPapers.length}/${countPerTopic} articles generated`);
  }

  // Save outputs
  const timestamp = Date.now();
  const sqlFile = path.join(__dirname, '..', `generated-${timestamp}.sql`);
  const jsonFile = path.join(__dirname, '..', `generated-${timestamp}.json`);

  if (sqlStatements.length > 0) {
    fs.writeFileSync(sqlFile, sqlStatements.join('\n'));
    fs.writeFileSync(jsonFile, JSON.stringify(allArticles, null, 2));
  }

  console.log('\n' + '='.repeat(50));
  console.log('ğŸ“Š Summary');
  console.log('='.repeat(50));
  console.log(`âœ… Total articles: ${allArticles.length}`);
  
  if (allArticles.length > 0) {
    console.log(`ğŸ“ SQL file: ${sqlFile}`);
    console.log(`ğŸ“ JSON file: ${jsonFile}`);
    
    if (importToDB) {
      console.log('\nğŸ”„ Importing to local database...');
      try {
        execSync(`npx wrangler d1 execute meddigest-db --local --file=${sqlFile}`, {
          cwd: path.join(__dirname, '..'),
          stdio: 'inherit'
        });
        console.log('âœ… Import completed successfully!');
      } catch (error) {
        console.error('âŒ Import failed:', error.message);
      }
    } else {
      console.log('\nğŸ“Œ To import to local DB:');
      console.log(`   npx wrangler d1 execute meddigest-db --local --file=${sqlFile}`);
      console.log('\nğŸ“Œ To import to production DB:');
      console.log(`   npx wrangler d1 execute meddigest-db --file=${sqlFile}`);
    }
  } else {
    console.log('âš ï¸ No articles generated');
  }
}

main().catch(console.error);
